CONTROLLED SUB-TESTOSTERONE
State of IllinoisIllinoisAmends the Illinois Controlled Substances Act. Provides that the Prescription Monitoring Program does not apply to testosterone, mifepristone, misoprostol, GnRH analogues, or estrogen. Provides that the Department of Human Services shall purge from the records of the Prescription Monitoring Program all existing information concerning the prescribing or dispensing of testosterone, including any such information contained in the central repository or database, on or before January 1, 2027, and shall ensure that no further records concerning the prescribing and dispensing of testosterone are created or maintained by the Prescription Monitoring Program. Provides that the Department shall update and adopt rules consistent with the provision no later than January 1, 2027. Effective immediately.
- Status
- Passed
- Signed or otherwise enacted
- Status date
- Jun 29, 2026
- 136 days ago
- Current chamber
- House of Representatives
- Session
- 2025-2026 Regular Session
Follow the legislation that affects what you sell.
Get started freeFree account · 30-second setup · No credit card
What it means for vendors
Civic IQ reads each bill for what it would fund, require or change for the agencies that buy.
Bill details
- Last action
- Public Act . . . . . . . . . 104-0535 · Jun 29, 2026
Sponsors
Show 26 more sponsors
Bill history
Newest first.
Show 51 earlier actions
Recorded votes
Read the bill at the source
This page follows the bill as the legislature records it. For the bill's full text and the official record, use the legislature's own site.
Bill data from LegiScan, licensed under CC BY 4.0.